1. Home
  2. RLAY vs GBX Comparison

RLAY vs GBX Comparison

Compare RLAY & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.81

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Greenbrier Companies Inc. (The)

GBX

Greenbrier Companies Inc. (The)

HOLD

Current Price

$48.73

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
GBX
Founded
2015
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Railroads
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
RLAY
GBX
Price
$7.81
$48.73
Analyst Decision
Strong Buy
Sell
Analyst Count
7
2
Target Price
$16.00
$45.00
AVG Volume (30 Days)
2.3M
487.7K
Earning Date
02-25-2026
01-08-2026
Dividend Yield
N/A
2.67%
EPS Growth
N/A
0.79
EPS
N/A
5.77
Revenue
$8,355,000.00
$3,070,400,000.00
Revenue This Year
$20.47
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$8.29
Revenue Growth
N/A
N/A
52 Week Low
$1.78
$37.77
52 Week High
$9.04
$71.06

Technical Indicators

Market Signals
Indicator
RLAY
GBX
Relative Strength Index (RSI) 47.13 55.17
Support Level $7.85 $47.18
Resistance Level $8.66 $54.15
Average True Range (ATR) 0.41 1.78
MACD -0.11 0.17
Stochastic Oscillator 18.41 33.76

Price Performance

Historical Comparison
RLAY
GBX

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.

Share on Social Networks: